Novavax granted fast track designation for NanoFlu in older adults

15 January 2020 - Novavax today announced that the U.S. FDA has granted fast track designation for NanoFlu, its recombinant quadrivalent ...

Read more →

Meissa Vaccines receives U.S. FDA fast track designation for respiratory syncytial virus vaccine, MV-012-968

10 January 2020 - Meissa Vaccines announced today that the U.S. FDA has granted fast track designation to MV-012-968, an ...

Read more →

PBAC – 2019 in review

8 January 2020 - The PBAC considered 188 submissions in 2019. ...

Read more →

Summary of submissions and outcomes from the November 2019 PBAC meeting

7 January 2020 - Analysis and insights from the November 2019 PBAC meeting. ...

Read more →

Meningococcal B vaccine rejected for inclusion on free schedule

22 December 2019 - It is the most common strain of deadly meningococcal disease, but the vaccine for the B strain ...

Read more →

First FDA approved vaccine for the prevention of Ebola virus disease, marking a critical milestone in public health preparedness and response

19 December 2019 - The U.S. FDA announced today the approval of Ervebo, the first FDA approved vaccine for the prevention ...

Read more →

Flawed forecasting? Why New Zealand ran out of MMR vaccine

16 December 2019 - PHARMAC's forecast for how many doses of MMR vaccine would be needed for 2019 was around ...

Read more →

Y-mAbs’ GD2-GD3 vaccine granted rare paediatric disease designation

12 December 2019 - Y-mAbs Therapeutics today announced that its GD2-GD3 vaccine has been granted a rare paediatric disease designation ...

Read more →

Seqirus announces Health Canada approval of first cell-based seasonal influenza vaccine

11 December 2019 - Seqirus, a global leader in influenza prevention, announced today that its cell-based quadrivalent influenza vaccine has ...

Read more →

2019-20 cost recovery implementation statement for PBS/NIP updated for 2018-19 financial outcome

12 December 2019 - The 2019–20 Cost Recovery Implementation Statement for the listing of medicines on the Pharmaceutical Benefits Scheme and ...

Read more →

Plans for measles vaccinations to be distributed back through PHARMAC

26 November 2019 - Measles vaccinations in the south will likely go back to being distributed by PHARMAC after being ...

Read more →

The life improvement value: a new measure of cost-efficiency

23 November 2019 - The decision not to make zoster vaccination available to people older than 79 years1 was based on ...

Read more →

Meningitis Foundation calls for PHARMAC to protect everyone

15 November 2019 - Following PHARMAC’s announcement stating the meningococcal ACWY vaccine will be available free from next month for ...

Read more →

PHARMAC widening access to the meningococcal ACWY vaccine

14 November 2019 - The meningococcal ACWY vaccine will be available free from next month for young people in close ...

Read more →

Merck’s Ervebo [Ebola Zaire vaccine (rVSVΔG-ZEBOV-GP) live] granted conditional approval in the European Union

12 November 2019 - Authorisation represents significant advancement in the global response to Ebola. ...

Read more →